Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25050546 |
US |
1 | |
Hallucination, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 702 | 25050582 |
US |
85 | 2 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 703 | 25050611 |
GB |
1 | |
Acute psychosis, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 704 | 25050839 |
|||
Pain, Rotator cuff syndrome, Intervertebral disc degeneration, Influenza, Therapy interrupted, Lip swelling, |
||||
LISINOPRIL, LENALIDOMIDE, |
||||
| 705 | 25050862 |
US |
28 | 1 |
Pneumonia, Product supply issue, Wrong technique in product usage process, Therapy interrupted, Product availability issue, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 706 | 25051326 |
1 | ||
Neck pain, Swelling, Spontaneous haemorrhage, Nephrolithiasis, Haematuria, Therapy interrupted, |
||||
EMICIZUMAB, |
||||
| 707 | 25051439 |
2 | ||
Arthralgia, Pain, Loss of personal independence in daily activities, Disturbance in social behaviour, Therapy interrupted, |
||||
ABALOPARATIDE, |
||||
| 708 | 25051681 |
38 | 2 | |
Influenza, Ear infection, Pharyngitis streptococcal, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 709 | 25051746 |
75 | 2 | |
Infection, Therapy interrupted, Psoriatic arthropathy, |
||||
UPADACITINIB, |
||||
| 710 | 25051914 |
GB |
54 | 1 |
Rheumatoid arthritis, General physical health deterioration, Illness, Mental disorder, Fatigue, Drug ineffective, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 711 | 25052409 |
US |
73 | 2 |
Pneumonia, COVID-19, Gastrointestinal perforation, Cerebrovascular accident, Visual impairment, Loss of consciousness, Deafness, Migraine, Chemical poisoning, Ill-defined disorder, Therapeutic product effect decreased, Memory impairment, Impaired driving ability, Rotator cuff syndrome, Thermal burn, Oropharyngeal pain, Nausea, Headache, Fall, Gastrointestinal disorder, Speech disorder, Tremor, Alopecia, Therapy interrupted, Incorrect disposal of product, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, RIMEGEPANT SULFATE, |
||||
| 712 | 25054139 |
US |
38 | 2 |
Rebound atopic dermatitis, Therapy interrupted, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 713 | 25057784 |
47 | 1 | |
Therapy interrupted, Adverse drug reaction, |
||||
AMBRISENTAN, |
||||
| 714 | 25057817 |
1 | ||
Psoriatic arthropathy, Large intestine perforation, Diverticulitis, Therapy interrupted, |
||||
GUSELKUMAB, |
||||
| 715 | 25057888 |
38 | 1 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 716 | 25057889 |
82 | 2 | |
Ear infection, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 717 | 25057969 |
76 | 2 | |
Cough, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 718 | 25057970 |
1 | ||
Drug ineffective, Pain, Therapy interrupted, |
||||
IXEKIZUMAB, LISINOPRIL, |
||||
| 719 | 25057974 |
49 | 2 | |
Malaise, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 720 | 25058102 |
68 | 2 | |
Abdominal pain upper, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 721 | 25059056 |
|||
Drug ineffective, Product use issue, Therapy interrupted, |
||||
| 722 | 25043568 |
US |
62 | 1 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 723 | 25043859 |
US |
54 | 2 |
Inability to afford medication, Therapy interrupted, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 724 | 25043909 |
NL |
2 | |
Spinal fracture, Therapy interrupted, |
||||
| 725 | 25045143 |
GB |
1 | |
Lower respiratory tract infection, Malaise, Headache, Illness, Therapy interrupted, Product prescribing issue, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 726 | 25045163 |
US |
||
Product prescribing issue, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 727 | 25045227 |
BR |
8 | 2 |
Inappropriate schedule of product administration, Therapy interrupted, Insurance issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 728 | 25045257 |
US |
74 | 2 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 729 | 25045306 |
US |
2 | |
Hallucination, Delusion, Unevaluable event, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 730 | 25045396 |
US |
1 | |
Hospitalisation, Atypical mycobacterial infection, Pneumonia, Drug ineffective, Treatment noncompliance, Therapy interrupted, Insurance issue, |
||||
AMIKACIN, AMIKACIN, |
||||
| 731 | 25045480 |
US |
30 | 1 |
Seizure, Product prescribing issue, Therapy interrupted, |
||||
BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, |
||||
| 732 | 25045494 |
CA |
73 | 1 |
Hospitalisation, Therapy interrupted, General physical condition abnormal, Poor venous access, Wrong technique in product usage process, Atrial appendage closure, Sleep disorder, Catheter site haemorrhage, |
||||
| 733 | 25045548 |
65 | 2 | |
COVID-19, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 734 | 25045549 |
61 | 2 | |
Malaise, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 735 | 25045562 |
52 | 2 | |
Pyrexia, Multiple allergies, Therapy interrupted, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 736 | 25045594 |
62 | 1 | |
COVID-19, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 737 | 25045599 |
67 | 1 | |
Skin ulcer, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 738 | 25045759 |
BR |
||
Femur fracture, Fall, Influenza like illness, Arthralgia, Pain, Peripheral swelling, Asthenia, Therapy partial responder, Therapy interrupted, Product availability issue, Intentional dose omission, Incorrect dose administered, Therapeutic response shortened, Product dispensing error, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, SIMVASTATIN, LOSARTAN, |
||||
| 739 | 25045996 |
US |
73 | 2 |
Hospitalisation, Therapy interrupted, Product use in unapproved indication, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 740 | 25045997 |
US |
2 | |
Neoplasm malignant, Brain fog, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 741 | 25046239 |
GB |
2 | |
Suicidal ideation, Psoriasis, Sneezing, Chills, Fatigue, Stress, Migraine, Rhinorrhoea, Nasopharyngitis, General physical health deterioration, COVID-19, Influenza, Illness, Product prescribing issue, Therapy interrupted, |
||||
METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, PROPRANOLOL HYDROCHLORIDE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, NAPROXEN, NAPROXEN SODIUM, INSULIN DEGLUDEC, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
| 742 | 25046840 |
US |
68 | 1 |
Hospitalisation, Product prescribing issue, Therapy interrupted, Product use issue, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 743 | 25047318 |
US |
||
Porphyria acute, Therapy interrupted, Product distribution issue, |
||||
GIVOSIRAN SODIUM, DULOXETINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, GABAPENTIN, POLYETHYLENE GLYCOL 3350, METHOCARBAMOL, METHOCARBAMOL TABLETS, SERTRALINE HYDROCHLORIDE, |
||||
| 744 | 25047346 |
US |
39 | 2 |
Lymphadenitis, Therapy interrupted, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALBUTEROL SULFATE, ALBUTEROL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, BENRALIZUMAB, GABAPENTIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ESCITALOPRAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, LEVOTHYROXINE SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 745 | 25047720 |
US |
||
Device defective, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 746 | 25047830 |
US |
||
Inability to afford medication, Therapy interrupted, Weight gain poor, Weight decreased, Diarrhoea, |
||||
PANCRELIPASE, PANCRELIPASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, |
||||
| 747 | 25047876 |
US |
65 | 1 |
Therapy interrupted, |
||||
ROMIPLOSTIM, |
||||
| 748 | 25047980 |
US |
35 | 1 |
Tremor, Dysstasia, Gait inability, Inability to afford medication, Therapy interrupted, |
||||
OZANIMOD HYDROCHLORIDE, OZANIMOD HYDROCHLORIDE, MESALAMINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SERTRALINE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 749 | 25048043 |
US |
1 | |
Therapy interrupted, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 750 | 25049924 |
65 | 2 | |
Nasopharyngitis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 751 | 25049933 |
51 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 752 | 25039039 |
US |
68 | 2 |
Insurance issue, Inability to afford medication, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 753 | 25039262 |
US |
38 | 1 |
Brain neoplasm, Tumour excision, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 754 | 25039385 |
US |
64 | 2 |
Psoriasis, Therapy interrupted, |
||||
APREMILAST, LITHIUM CARBONATE, DIVALPROEX SODIUM, PALIPERIDONE, ALLOPURINOL, LEVOTHYROXINE SODIUM, BRIMONIDINE TARTRATE, OIL, BIOTIN, HAIR, VIBEGRON, SEMAGLUTIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 755 | 25039930 |
US |
60 | 1 |
Swelling, Rash, Hospitalisation, Product dose omission issue, Therapy interrupted, Incorrect dose administered, Drug dose omission by device, Device leakage, |
||||
AMIKACIN, AMIKACIN, |
||||
| 756 | 25039983 |
US |
61 | 1 |
Product distribution issue, Therapy interrupted, Off label use, |
||||
| 757 | 25040280 |
US |
||
Nocturia, Therapeutic product effect variable, Therapy interrupted, |
||||
VIBEGRON, PANTOPRAZOLE SODIUM, FAMOTIDINE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, |
||||
| 758 | 25040415 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, ERGOCALCIFEROL, METOPROLOL TARTRATE, METOPROLOL, POTASSIUM CHLORIDE, FUROSEMIDE, |
||||
| 759 | 25040531 |
US |
1 | |
Seizure, Epilepsy, Microcephaly, Developmental delay, Tachycardia, Therapy interrupted, |
||||
FENFLURAMINE, FENFLURAMINE, LEVETIRACETAM, LEVETIRACETAM, CLONAZEPAM, GABAPENTIN, DIAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, POLYETHYLENE GLYCOL 3350, |
||||
| 760 | 25040640 |
US |
83 | 1 |
Dizziness, Device difficult to use, Accidental exposure to product, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 761 | 25040759 |
84 | 2 | |
Febrile neutropenia, Liver abscess, Sepsis, Small intestinal obstruction, Therapy interrupted, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 762 | 25040811 |
US |
59 | 2 |
Psoriatic arthropathy, Product availability issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, RISANKIZUMAB-RZAA, |
||||
| 763 | 25041112 |
US |
65 | 2 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 764 | 25041253 |
US |
1 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 765 | 25041336 |
2 | ||
Cerebrovascular accident, Therapy interrupted, |
||||
ALIROCUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 766 | 25041365 |
GB |
1 | |
Hospitalisation, Therapy interrupted, Treatment noncompliance, |
||||
CLOZAPINE, |
||||
| 767 | 25041374 |
US |
2 | |
Chest pain, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, ALLOPURINOL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE, MELATONIN, CARBIDOPA AND LEVODOPA, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, |
||||
| 768 | 25041463 |
US |
48 | 1 |
Hospitalisation, Tongue biting, Psychiatric decompensation, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 769 | 25042163 |
US |
2 | |
Dental operation, Off label use, Product availability issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 770 | 25042499 |
US |
2 | |
Haematological infection, Therapy interrupted, |
||||
PATIROMER, |
||||
| 771 | 25042547 |
|||
Nervousness, Gait disturbance, Therapy interrupted, |
||||
FINGOLIMOD HCL, |
||||
| 772 | 25043050 |
US |
2 | |
Blood potassium decreased, Diarrhoea, Therapy interrupted, |
||||
TENAPANOR HYDROCHLORIDE, CHLORTHALIDONE, |
||||
| 773 | 25043177 |
CA |
1 | |
Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 774 | 25043187 |
IT |
9 | 1 |
Therapy interrupted, Device mechanical issue, Device difficult to use, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 775 | 25043227 |
US |
81 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 776 | 25043385 |
TN |
30 | 1 |
Shock, Fall, Paralysis, Urinary incontinence, Stress, Insomnia, Vision blurred, Therapy interrupted, |
||||
INTERFERON BETA-1A, |
||||
| 777 | 25043386 |
US |
38 | 1 |
Small intestine adenocarcinoma, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 778 | 25043398 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 779 | 25045411 |
54 | 1 | |
Infection, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 780 | 25045441 |
77 | 1 | |
Hospitalisation, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 781 | 25045442 |
66 | 1 | |
Heart transplant rejection, Therapy interrupted, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 782 | 25045854 |
|||
Irritability, Condition aggravated, Therapy interrupted, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 783 | 25034048 |
ES |
||
Inflammatory bowel disease, Abortion spontaneous, Premature delivery, Caesarean section, Rheumatic disorder, Musculoskeletal disorder, Pre-eclampsia, Labour induction, Breech presentation, Failed induction of labour, Cephalo-pelvic disproportion, Infection, Urinary tract infection, Respiratory tract infection, Maternal exposure during pregnancy, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 784 | 25034441 |
US |
2 | |
Weight increased, Product dispensing error, Blood cholesterol increased, Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 785 | 25034562 |
US |
||
Product temperature excursion issue, Product distribution issue, Therapy interrupted, Intentional product use issue, |
||||
ADALIMUMAB, ADALIMUMAB, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, MOMETASONE FUROATE, MOMETASONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, MUPIROCIN, MUPIROCIN CALCIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 786 | 25034589 |
US |
||
Therapy interrupted, |
||||
ADALIMUMAB, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, CARVEDILOL, APIXABAN, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, GABAPENTIN, PREDNISONE, |
||||
| 787 | 25034610 |
US |
||
Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 788 | 25034687 |
US |
35 | 2 |
Seizure, Product availability issue, Therapy interrupted, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 789 | 25034782 |
US |
1 | |
Hospitalisation, Device connection issue, Device issue, Drug dose omission by device, Product dose omission issue, Therapy interrupted, Intentional dose omission, |
||||
AMIKACIN, |
||||
| 790 | 25035136 |
US |
||
Therapy interrupted, |
||||
BOSENTAN, |
||||
| 791 | 25035137 |
US |
||
Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 792 | 25035405 |
US |
72 | 1 |
Hallucination, Delusion, Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 793 | 25035421 |
CO |
81 | 2 |
Multiple organ dysfunction syndrome, Pulmonary oedema, Bronchitis, Anaemia, Haemoglobin decreased, Blood pressure increased, Arthralgia, Therapy interrupted, Insurance issue, Off label use, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 794 | 25035449 |
US |
2 | |
Pain, Therapy interrupted, |
||||
APREMILAST, USTEKINUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CALCIUM CARBONATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 795 | 25035537 |
US |
||
Bone density decreased, Therapy interrupted, |
||||
| 796 | 25035582 |
CO |
56 | 2 |
Rheumatoid arthritis, Influenza, Conjunctivitis, Off label use, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CALCIUM, FOLIC ACID, |
||||
| 797 | 25035592 |
US |
73 | 1 |
Pneumonia, Pneumonia, Respiratory tract congestion, Blood pressure increased, Cough, Off label use, Therapy interrupted, |
||||
ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CLONAZEPAM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LEVOTHYROXINE, GUAIFENESIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, TIOTROPIUM BROMIDE, TORSEMIDE, ERGOCALCIFEROL, |
||||
| 798 | 25035651 |
CO |
82 | 1 |
Cerebrovascular accident, Muscle rigidity, Product dispensing issue, Therapy interrupted, |
||||
ROTIGOTINE, ROTIGOTINE, LOSARTAN, LINAGLIPTIN, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RIVAROXABAN, |
||||
| 799 | 25035790 |
51 | 1 | |
Influenza, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 800 | 25035792 |
61 | 2 | |
Adverse drug reaction, Myasthenia gravis, Eyelid function disorder, Therapy interrupted, |
||||
PEMBROLIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28